24 May 2013
Keywords: taro, gains, final, fda, appro, cetirizine, israel-headquartered
Article | 30 June 2008
Israel-headquartered Taro Pharmaceutical Industries, which recently pulled out of a merger deal with India's Sun Pharmaceuticals (Marketletter June 9), says that ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.